Key facts
- This page summarizes Michel Lagarde's Form 3 filing for WEST PHARMACEUTICAL SERVICES INC (WST).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Sep 2026, 15:33.
Michel Lagarde - 31 Aug 2026 Form 3 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- WST
- Reported as of
- 31 Aug 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 10 Sep 2026, 15:33:35 UTC
- Prior SEC filing
- 05 May 2026
- Next SEC filing
- 10 Sep 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Louis Lalli, as an agent for Michel Lagarde
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michel Lagarde filed Form 3 for WEST PHARMACEUTICAL SERVICES INC (WST) on 10 Sep 2026.
Change
- Previous filing in this sequence was filed on 05 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001518973
Primary reporting owner
Lagarde Michel
- Relationship
- President and CEO, Director
- Address
- 530 HERMAN O. WEST DRIVE, EXTON
- Signature
- /s/ Louis Lalli, as an agent for Michel Lagarde
- Signature date
- 10 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
WST
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,850
- Date
- 31 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.